Gain Therapeutics Inc GANX Q1 2026 Earnings Narrower Loss Surpasses Estimates Stock Edges Higher enVVeno Medical NVNO Q3 2025 Earnings NarrowerThanExpected Loss Signals Cost Discipline Progress ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance LVLU Q1 2026 Earnings Massive EPS Miss Sends Stock Lower SKIN Q1 2026 Earnings EPS Beats Estimates Amid NarrowerThanExpected Loss SIM Q1 2023 Earnings Sharp EPS Miss Amid Challenging Steel Market Conditions